Based on Tengion's understanding of hollow organ regeneration and clinical advances with the Neo-Urinary Conduit™, as well as principles demonstrated with its Neo-Bladder Augment™ product, Tengion is seeking to partner a preclinical stage asset for gastrointestinal regeneration. Tengion continues to advance this technology through the patent process and seeks scientific community input for these product candidates through scientific publications and presentations.
Tengion is advancing the Neo-GI Augment technology with the goal of using a patient's own cells to build gastrointestinal solutions for patients who have a need for esophageal or intestinal tissue.
Based on the principles demonstrated with its Neo-Bladder Augment™, Tengion is also seeking to partner its Neo-Vessel Replacement™ technology. Tengion has published several scientific papers outlining its progress with Neo-Vessel Replacement™ product candidates and continues to advance this technology through the patent process.
Tengion's Neo-Vessel Replacement is being advanced with the goal of using a patient's own cells to build blood vessels for patients that need vascular access for dialysis and for patients who are receiving peripheral bypass surgery or coronary artery bypass surgery.